Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
59 hedge funds and large institutions have $82.9M invested in Thorne Healthtech, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 9 closing their positions.
245% more capital invested
Capital invested by funds: $24M → $82.9M (+$58.9M)
167% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 9
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
34% more funds holding
Funds holding: 44 → 59 (+15)
31% less call options, than puts
Call options by funds: $107K | Put options by funds: $156K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$10.1M |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
+$6.36M |
| 3 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$4.75M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$4.65M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$4.58M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$3.87M |
| 3 |
RA
Royce & Associates
New York
|
-$892K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$814K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$329K |
THRN Hedge Fund Activity: Q3 2023 in Review
59 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q3 2023, worth a combined $82.9M — up 245% from $24M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new THRN positions and 9 closed out — a net gain of 15 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $10.1M. The largest seller was Emerald Advisers, exiting entirely with an estimated $4.58M sold.
- 59 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q3 2023, up from 44 in Q2 2023.
- Funds reported $82.9M of Thorne Healthtech, Inc. Common Stock stock for Q3 2023, up 245% quarter-over-quarter.
- 24 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q3 2023 and 9 closed out, a net change of +15 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q3 2023 was Glazer Capital LLC, an estimated $10.1M added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q3 2023 was Emerald Advisers, an estimated $4.58M sold.
Based on aggregated 13F filings for Q3 2023.